Home Search Browse Download Submit Help

    Associated keywords: Bone metabolism and other diseases
    RESULT:
PMID: Species: ncRNA Symbol: Diseases: Description the function of ncRNA: Details:
27695455 Rattus norvegicus miR-326 Acute Graft-versus-Host Disease In the skin, upregulation of miR-34b and downregulation of miR-326 was observed Detail
26273623 Homo sapiens hsa-miR-494 Ankylosing Spondylitis Probably higher in AS group than in control group Detail
26273623 Homo sapiens hsa-miR-142 3p Ankylosing Spondylitis Probably higher in AS group than in control group Detail
26273623 Homo sapiens hsa-miR-515 3p Ankylosing Spondylitis Probably higher in AS group than in control group Detail
26273623 Homo sapiens hsa-miR-15a Ankylosing Spondylitis Probably higher in AS group than in control group Detail
26273623 Homo sapiens hsa-miR-202 Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 6 downregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hmp predicated miR-216 Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 6 downregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens mmu-miR-379 Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 6 downregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hmp predicated miR-207 Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 6 downregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hmp predicated miR-112 Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 6 downregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-17 5p Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 6 downregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-451 Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-199a Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-30b Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa let 7i Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-142 5p Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-106b Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-146b Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-101 Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens mmu-miR-146 Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-181a Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-15b Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-19a Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-126 Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-29b Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-146a Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hmp predicated miR-121 Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-126 Ankylosing Spondylitis 23 of them had definite expression regulation after therapy. Among them, the expression levels of 17 upregulated significantly after regular etanercept therapy. Detail
26273623 Homo sapiens hsa-miR-526a Ankylosing Spondylitis 13 microRNAs were thought to keep different expression levels, not so dramatically changed in AS group before and after etanercept therapy Detail
26273623 Homo sapiens hsa-miR-515 3p Ankylosing Spondylitis 13 microRNAs were thought to keep different expression levels, not so dramatically changed in AS group before and after etanercept therapy Detail
26273623 Homo sapiens hsa-miR-494 Ankylosing Spondylitis 13 microRNAs were thought to keep different expression levels, not so dramatically changed in AS group before and after etanercept therapy Detail
26273623 Homo sapiens hmp predicted miR-206 Ankylosing Spondylitis 13 microRNAs were thought to keep different expression levels, not so dramatically changed in AS group before and after etanercept therapy Detail
26273623 Homo sapiens hmp predicted miR-191 Ankylosing Spondylitis 13 microRNAs were thought to keep different expression levels, not so dramatically changed in AS group before and after etanercept therapy Detail
26273623 Homo sapiens hsa-miR-92 Ankylosing Spondylitis 13 microRNAs were thought to keep different expression levels, not so dramatically changed in AS group before and after etanercept therapy Detail
26273623 Homo sapiens hsa-miR-93 Ankylosing Spondylitis 13 microRNAs were thought to keep different expression levels, not so dramatically changed in AS group before and after etanercept therapy Detail
26273623 Homo sapiens hsa-miR-103 Ankylosing Spondylitis 13 microRNAs were thought to keep different expression levels, not so dramatically changed in AS group before and after etanercept therapy Detail
26273623 Homo sapiens hsa-miR-29a Ankylosing Spondylitis 13 microRNAs were thought to keep different expression levels, not so dramatically changed in AS group before and after etanercept therapy Detail
26273623 Homo sapiens hsa-miR-20a Ankylosing Spondylitis 13 microRNAs were thought to keep different expression levels, not so dramatically changed in AS group before and after etanercept therapy Detail
26273623 Homo sapiens hsa-miR-29c Ankylosing Spondylitis 13 microRNAs were thought to keep different expression levels, not so dramatically changed in AS group before and after etanercept therapy Detail
26273623 Homo sapiens hsa-miR-26b Ankylosing Spondylitis 13 microRNAs were thought to keep different expression levels, not so dramatically changed in AS group before and after etanercept therapy Detail
28848993 Rattus norvegicus miR-19b-3p Deep vein thrombosis Differential expression of 6 upregulated miRNAs in the DVT, the control and the sham group. Detail
28848993 Rattus norvegicus miR-142-5p Deep vein thrombosis Differential expression of 6 upregulated miRNAs in the DVT, the control and the sham group. Detail
28848993 Rattus norvegicus miR-15a-5p Deep vein thrombosis Differential expression of 6 upregulated miRNAs in the DVT, the control and the sham group. Detail
28848993 Rattus norvegicus miR-92a-3p Deep vein thrombosis Differential expression of 6 upregulated miRNAs in the DVT, the control and the sham group. Detail
28848993 Rattus norvegicus miR-486 Deep vein thrombosis Differential expression of 6 upregulated miRNAs in the DVT, the control and the sham group. Detail
28848993 Rattus norvegicus miR-128-3p Deep vein thrombosis Differential expression of 6 upregulated miRNAs in the DVT, the control and the sham group. Detail
28848993 Rattus norvegicus miR-218a-5p Deep vein thrombosis Differential expression of 13 downregulated miRNAs in the DVT, the vontrol and the sham group. Detail
28848993 Rattus norvegicus miR-204-5p Deep vein thrombosis Differential expression of 13 downregulated miRNAs in the DVT, the vontrol and the sham group. Detail
28848993 Rattus norvegicus miR-133b-3p Deep vein thrombosis Differential expression of 13 downregulated miRNAs in the DVT, the vontrol and the sham group. Detail
28848993 Rattus norvegicus miR-10b-5p Deep vein thrombosis Differential expression of 13 downregulated miRNAs in the DVT, the vontrol and the sham group. Detail
28848993 Rattus norvegicus miR-10a-5p Deep vein thrombosis Differential expression of 13 downregulated miRNAs in the DVT, the vontrol and the sham group. Detail
28848993 Rattus norvegicus miR-143-3p Deep vein thrombosis Differential expression of 13 downregulated miRNAs in the DVT, the vontrol and the sham group. Detail
28848993 Rattus norvegicus miR-195-5p Deep vein thrombosis Differential expression of 13 downregulated miRNAs in the DVT, the vontrol and the sham group. Detail
28848993 Rattus norvegicus miR-497-5p Deep vein thrombosis Differential expression of 13 downregulated miRNAs in the DVT, the vontrol and the sham group. Detail
28848993 Rattus norvegicus miR-27b-3p Deep vein thrombosis Differential expression of 13 downregulated miRNAs in the DVT, the vontrol and the sham group. Detail
28848993 Rattus norvegicus miR-196a-5p Deep vein thrombosis Differential expression of 13 downregulated miRNAs in the DVT, the vontrol and the sham group. Detail
28848993 Rattus norvegicus miR-23b-3p Deep vein thrombosis Differential expression of 13 downregulated miRNAs in the DVT, the vontrol and the sham group. Detail
28848993 Rattus norvegicus miR-196b-5p Deep vein thrombosis Differential expression of 13 downregulated miRNAs in the DVT, the vontrol and the sham group. Detail
28848993 Rattus norvegicus miR-125a-5p Deep vein thrombosis Differential expression of 13 downregulated miRNAs in the DVT, the vontrol and the sham group. Detail
25244974 Rattus norvegicus miR-582 Deep vein thrombosis Serum miR-582, miR-195 and miR-532 might have potential to be a novel noninvasive biomarkers for detection of DVT Detail
25244974 Rattus norvegicus miR-195 Deep vein thrombosis Serum miR-582, miR-195 and miR-532 might have potential to be a novel noninvasive biomarkers for detection of DVT Detail
25814674 Homo sapiens hsa-miR-649 Diabetic wound-healing Inflammation underlying nonhealing wounds in patients with type 2 diabetes mellitus influences plasma miRNA concentRattus norvegicusions Detail
23227223 Homo sapiens miR-26a Fibrodysplasia ossificans progressiva mir148b and mir365 were able to down-regulate ACVR1/Alk-2 expression, whereas mir26a showed a positive effect on its mRNA. Detail
28460412 Homo sapiens miR-615-3p Heterotopic ossification MiR-615-3p negatively regulates the osteogenic differentiation of hLF cells through post-transcriptionally suppressing osteogenic regulators GDF5 and FOXO1. Detail
27756280 Mus musculus shRNA TNF-a Osteolysis Lentivirus-mediated shRNA targeting the TNF-alpha gene successfully inhibited particle-induced inflammatory and osteolytic changes both in vitro and in vivo. Detail
28382864 Mus musculus miR-130b Osteolysis (Particle-Induced) The upregulated miR-130b in PIO models could act as one key regulator of PIO development, partly due to its negative regulation on FRZB. Detail
27607236 Homo sapiens NONSAT093218 Osteomyelitis The top 20 up-regulated lncRNAs during osteogenic differentiation of hBMSCs treated by Staphylococcal protein A. Detail
27607236 Homo sapiens NONSAT070565 Osteomyelitis The top 20 up-regulated lncRNAs during osteogenic differentiation of hBMSCs treated by Staphylococcal protein A. Detail
27607236 Homo sapiens NONHSAT132944 Osteomyelitis The top 20 up-regulated lncRNAs during osteogenic differentiation of hBMSCs treated by Staphylococcal protein A. Detail
27607236 Homo sapiens NONHSAT1144067 Osteomyelitis The top 20 down-regulated lncRNAs during osteogenic differentiation of hBMSCs treated by Staphylococcal protein A. Detail
27607236 Homo sapiens NR_033772.1 Osteomyelitis The top 20 down-regulated lncRNAs during osteogenic differentiation of hBMSCs treated by Staphylococcal protein A. Detail
27607236 Homo sapiens TCONS_00021560 Osteomyelitis The top 20 down-regulated lncRNAs during osteogenic differentiation of hBMSCs treated by Staphylococcal protein A. Detail
27552543 Homo sapiens miR-30e-5p Osteoporosis Specific serum miRNA profiles are strongly related to bone pathologies. Detail
27552543 Homo sapiens miR-186-5p Osteoporosis Specific serum miRNA profiles are strongly related to bone pathologies. Detail
27552543 Homo sapiens miR-532-5p Osteoporosis Significant correlations between BMDL1–L4 and miR-532-5p Detail
27552543 Homo sapiens miR-93-5p Osteoporosis Significant correlations between BMDL1–L4 and miR-93-5p Detail
27552543 Homo sapiens miR-378a-5p Osteoporosis Specific serum miRNA profiles are strongly related to bone pathologies. Detail
27552543 Homo sapiens miR-16-5p Osteoporosis Specific serum miRNA profiles are strongly related to bone pathologies. Detail
26555194 Homo sapiens hsa-miR-25-3p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-26b-5p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-320a Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-320b Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-320c Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-320d Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-320e Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-32-3p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-339-5p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-3591-5p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-3607-3p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-3607-5p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-3609 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-361-3p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-3621 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-3654 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-423-3p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4258 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4284 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4306 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4317 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4449 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4455 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4458 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4463 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4484 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4497 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4516 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4532 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4534 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4540 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4640-3p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4687-3p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4732-3p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4741 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-4792 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-483-5p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-491-3p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-519e-5p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-542-5p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-5681b Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-5684 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-5701 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-574-5p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-631 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-642a-3p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-642b-3p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-664b-5p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-675-5p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-711 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-99a-5p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miR-99b-5p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsa-miRPlus-A1015 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsv1-miR-H18 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens hsv1-miR-H6-5p Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens SNORD10 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens SNORD38B Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens SNORD44 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens SNORD49A Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens SNORD4A Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
26555194 Homo sapiens SNORD68 Osteoporosis Significant differentially expressed miRNAs between osteoporotic and control bone samples。 Detail
27345526 Homo sapiens hsa-miR-550a-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-203a Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-19b-1-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-942 Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-500a-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-181c-3p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-7-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-96-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-323a-3p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-141-3p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-32-3p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-16-2-3p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-let-7i-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-let-7g-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-486-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-92a-3p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-21-3p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-375 Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-181c-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-191-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-let-7b-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-143-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-382-3p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control Detail
27345526 Homo sapiens hsa-miR-382-3p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-181a-3p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-188-3p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-942 Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-642a-5p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-127-3p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-582-3p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-542-5p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-502-5p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-576-3p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-190a Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-378a-5p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-1908 Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-155-5p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-342-5p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-377-3p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-369-3p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-495-3p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-203a Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-181d Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-550a-5p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Postmenopausal osteoporosis fracture versus control. Detail
27345526 Homo sapiens hsa-miR-550a-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-203a Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-19b-1-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-942 Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-500a-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-181c-3p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-7-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-96-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-323a-3p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-141-3p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-32-3p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-375 Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-181c-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-191-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-let-7b-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-143-5p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-382-3p Osteoporosis Top 23 Regulated miRNAs in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-642a-5p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-502-5p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-576-3p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-190a Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-378a-5p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-1908 Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-155-5p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-342-5p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-377-3p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-369-3p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-495-3p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27345526 Homo sapiens hsa-miR-500a-5p Osteoporosis All 23 Regulated miRNAs in Nondiabetic Postmenopausal Women With and Without History of Fragility Fractures. Type 2 diabetes fracture versus diabetic control. Detail
27821865 Rattus norvegicus miR-30e-5p Osteoporosis 14 miRNAs were down-regulated but no miRNA was up-regulated among above three altered miRNAs from microarray in OVX serum by normalizing to miR-25-3p Detail
27821865 Rattus norvegicus miR-142-3p Osteoporosis 14 miRNAs were down-regulated but no miRNA was up-regulated among above three altered miRNAs from microarray in OVX serum by normalizing to miR-25-3p Detail
26783047 Mus musculus miR-340-5p Osteoporosis Six miRNAs were associated with the progression of osteoporosis Detail
26783047 Mus musculus miR-27a-3p Osteoporosis Six miRNAs were associated with the progression of osteoporosis Detail
27337099 Homo sapiens hsa-miR-1306 Osteoporosis Downregulated miRNAs in the serum of osteoporosis patients. Detail
27337099 Homo sapiens hsa-miR-197 Osteoporosis Downregulated miRNAs in the serum of osteoporosis patients. Detail
27337099 Homo sapiens hsa-miR-663a Osteoporosis Downregulated miRNAs in the serum of osteoporosis patients. Detail
26824232 Mus musculus Snord116 Osteoporosis (Prader-Willi Syndrome) SnoRNA Snord116 as a critical contributor to the development of PWS exhibiting many of the classical symptoms of Prader-Willi Syndrome. PWCR which includes Snord116 in mice leads to a reduced bone mass phenotype, similar to that observed in humans. Detail
27836951 Homo sapiens miR-21-5p Osteoporosis/fracture The expression of miR-21-5p was significantly lower among osteoporotic/osteopenic women with VFs, showing 66% sensitivity and 77% specificity in distinguishing women with a vertebral fracture Detail
28933035 Homo sapiens miR-20a-5p Postmenopausal osteoporosis Top ten most expressed miRNAs in the bone tissue array. Detail
28933035 Homo sapiens miR-126-3p Postmenopausal osteoporosis Top ten most expressed miRNAs in the bone tissue array. Detail
28933035 Homo sapiens miR-4284 Postmenopausal osteoporosis Top ten most expressed miRNAs in the bone tissue array. Detail
28933035 Homo sapiens miR-3614-3p Postmenopausal osteoporosis Top ten most expressed miRNAs in the hOB array (listed in order of expression levels) and the overlap in total bone tissue and hOC arrays Detail

 

 


 

 

ODNA
Harbin Medical University, China